arrow
K

Klaus Hirschbühl

medical faculty
H指数:13
被引数:1,109

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Multimodal profiling of immune responses reveals innate-adaptive immune imbalance in human bornavirus encephalitis

多模态免疫反应分析揭示人类博尔纳病毒脑炎中固有免疫与适应性免疫失衡

2026-05-140
OA
Development of a prognostic scoring system for chronic myeloid leukemia in blast phase

慢性髓性白血病急变期预后评分系统的开发

Leukemia
IF13.4
2026-02-190
OA
Molecular Genetic Analysis of Bone Marrow Core Biopsy as an Alternative or Adjunct to Bone Marrow Aspirate and/or Peripheral Blood in Hematologic Myeloid Neoplasms

骨髓芯针活检的分子遗传学分析作为血液系统髓系肿瘤中骨髓抽吸物和/或外周血的替代或辅助手段

2025-04-140
OA
Liver-FDG-uptake augments early PET/CT prognostic value for CD19-targeted CAR-T cell therapy in diffuse large B cell lymphoma
2025-03-170
OAAI
Pretransplant MRD does not seem to affect survival in NPM1-mutated AML undergoing allogeneic stem cell transplantation

移植前微小残留病(MRD)似乎不影响接受allo-HSCT的NPM1突变型急性髓系白血病患者的生存。

2025-02-040
OA
Management and outcome of patients with chronic myeloid leukemia in blast phase in the tyrosine kinase inhibitor era - analysis of the European LeukemiaNet Blast Phase Registry
LEUKEMIA
IF13.4
2024-03-284
OAAI
High viral loads: what drives fatal cases of COVID-19 in vaccinees? - an autopsy study
2022-08-017
OAAI
Treatment of myeloid malignancies relapsing after allogeneic hematopoietic stem cell transplantation with venetoclax and hypomethylating agents-a retrospective multicenter analysis on behalf of the German Cooperative Transplant Study Group (vol 100, pg 959, 2021)
2021-06-231
OAAI
Treatment of myeloid malignancies relapsing after allogeneic hematopoietic stem cell transplantation with venetoclax and hypomethylating agents-a retrospective multicenter analysis on behalf of the German Cooperative Transplant Study Group
2020-11-1640
OAAI